SynthesisAlimentary pharmacology & therapeutics2021

Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases.

Joseph Meserve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.